AIMS AND OBJECTIVES
The main objective of this five year study is to determine the effectiveness of a comprehensive antistigma/recovery-oriented intervention in reducing stigmatizing attitudes and behaviours among PHC providers toward individuals with MISUP in the Brazilian context, using FHUs as the point of intervention. This study will involve two conditions: Control: Three FHUs in the municipality of Ribeirão Preto will be randomly selected as controls. Experimental: Three FHUs in the municipality of Ribeirão Preto will be randomly selected to receive the intervention. Specific Hypotheses 1. Participation in the experimental group will result in a significant decrease in stigmatizing attitudes among PHC providers toward individuals with MISUP compared with the control group. 2. Participation in the experimental group will result in a significant decrease of service user’s experiences of MISUP stigma conveyed by PHC providers compared with the control group. Secondary Hypothesis 1. Changes in attitudes and behaviours within the experimental group will be sustained over time.
The proposed research is unique in several respects: 1. This is the first Brazilian study to evaluate a comprehensive anti-stigma intervention targeting FHU providers from an organizational perspective.
Sao Paulo Research Foundation (FAPESP)
2. This is the first Brazilian cluster randomized controlled trial to test the effectiveness of a standardized intervention aimed at reducing stigmatizing attitudes and practices of FHU providers toward people with MISUP. 3. This will lead to the first evidence-based, standardized, validated recovery-oriented anti-stigma intervention targeting FHU providers, which may be scaled up to other FHUs and primary health care centres across Brazil, including but not limited to, Basic Health Units, Health Centres, Social Community Health Centres and Emergency Medical Care Centres.
Dr. Carla Ventura, the nominated Principal Applicant, was the Academic Coordinator of the International Research Capacity Building Program for Health Related Professionals to study the Drug Phenomenon in Latin America and the Caribbean (IRCBP), organized by CAMH in partnership with the Organization of American States, in 2014 and 2015. In 2014, she was a Fulbright Scholar at the Center for Civil and Human Rights, University of Notre Dame, South Bend. Currently, she is an Associate Professor at the Department of Psychiatric Nursing and Human Sciences from the University of São Paulo at Ribeirão Preto College of Nursing,
- São Paulo Research Foundation, Brazil